Kevin Conway's Insider Trades & SAST Disclosures
Kevin Conway's most recent trade in Generation Bio Co was a trade of 587 Restricted Stock Units done . Disclosure was reported to the exchange on April 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kevin Conway.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 587 | 4,107 | - | - | Restricted Stock Units | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 587 | 18,032 | - | - | Common Stock | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 15 Apr 2025 | 173 | 17,859 | - | 0.4 | 64 | Common Stock |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 587 | 4,694 | - | - | Restricted Stock Units | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 587 | 17,649 | - | - | Common Stock | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 15 Jan 2025 | 204 | 17,445 | - | 0.9 | 181 | Common Stock |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 355,260 | 355,260 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges